Evidence map›Paper›PMID 34164371›Full record

ReviewFrontiers in public health2021

Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools.

Shanshan Liu, Qiuyue Li, Xuntao Chu, Minxia Zeng, Mingbin Liu, Xiaomeng He, Heng Zou, Jianghua Zheng, Christopher Corpe, Xiaoyan Zhang and 2 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shanshan LiuShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Qiuyue LiShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Xuntao ChuZhuhai Livzon Diagnostics Inc., Guangdong, China.
Minxia ZengZhuhai Livzon Diagnostics Inc., Guangdong, China.
Mingbin LiuShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Xiaomeng HeShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Heng ZouShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Jianghua ZhengDepartment of Laboratory Medicine, Zhoupu Hospital Affiliated to Shanghai University of Medicine and Health Sciences, Shanghai, China.
Christopher CorpeNutritional Science Department, King's College London, London, United Kingdom.
Xiaoyan ZhangShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Jianqing XuShanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Jin WangShanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) pneumonia is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has rapidly become a global public health concern. As the new type of

Indexed as

COVID-19COVID-19 TestingClinical Laboratory TechniquesHumansSARS-CoV-2Sensitivity and SpecificitycoronavirusCOVID-19immunoassayrRT-PCRSARS-CoV-2

Identifiers

PMID34164371
PMCPMC8215441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.